LivaNova (NASDAQ:LIVN) Reaches New 1-Year Low - Time to Sell?

LivaNova PLC (NASDAQ:LIVN - Get Free Report)'s stock price reached a new 52-week low during mid-day trading on Friday . The company traded as low as $35.44 and last traded at $36.48, with a volume of 823 shares trading hands. The stock had previously closed at $37.48.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on LIVN. Stifel Nicolaus decreased their price target on LivaNova from $72.00 to $60.00 and set a "buy" rating for the company in a report on Wednesday, February 26th. Barclays reduced their target price on shares of LivaNova from $58.00 to $56.00 and set an "equal weight" rating for the company in a research note on Friday, March 7th. Wolfe Research lowered shares of LivaNova from an "outperform" rating to a "peer perform" rating in a research note on Wednesday, February 26th. The Goldman Sachs Group cut their price target on shares of LivaNova from $64.00 to $55.00 and set a "buy" rating for the company in a report on Monday, March 3rd. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $64.00 price objective on shares of LivaNova in a report on Monday, March 17th. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of $61.17.

LivaNova Trading Up 2.0 %

The firm has a market cap of $1.88 billion, a PE ratio of 82.79 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87. The business has a 50-day moving average price of $42.52 and a two-hundred day moving average price of $47.76.

Hedge Funds Weigh In On LivaNova

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Russell Investments Group Ltd. increased its stake in shares of LivaNova by 17.1% during the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock worth $70,000 after purchasing an additional 219 shares in the last quarter. Sterling Capital Management LLC increased its position in LivaNova by 800.6% during the fourth quarter. Sterling Capital Management LLC now owns 1,621 shares of the company's stock worth $75,000 after buying an additional 1,441 shares in the last quarter. Central Pacific Bank Trust Division raised its holdings in shares of LivaNova by 7.0% in the first quarter. Central Pacific Bank Trust Division now owns 4,407 shares of the company's stock worth $173,000 after acquiring an additional 290 shares during the last quarter. Vestcor Inc purchased a new stake in shares of LivaNova in the fourth quarter valued at $204,000. Finally, Optimize Financial Inc acquired a new stake in shares of LivaNova during the fourth quarter valued at $208,000. Institutional investors and hedge funds own 97.64% of the company's stock.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.